Related Experiment Video
Updated: Sep 11, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Understanding obesity in children with 22q11.2 deletion syndrome
Walter Maria Sarli1,2, Matteo Cerutti2, Matteo Pontone2
1Immunology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Insights
Obesity in 22q11.2 deletion syndrome (22q11.2DS) is linked to psychoactive medication, not the syndrome itself. Early intervention and careful drug use are key to managing weight gain in affected children.
Area of Science:
- Genetics and Pediatrics
- Metabolic Health and Endocrinology
Background:
- 22q11.2 deletion syndrome (22q11.2DS) is a complex genetic disorder.
- While short stature is documented, weight excess data in pediatric patients are limited.
Purpose of the Study:
- Evaluate overweight and obesity prevalence in pediatric 22q11.2DS patients compared to the general Italian population.
- Identify risk factors and critical periods for weight gain in 22q11.2DS.
Main Methods:
- Retrospective, single-center study of 61 children with confirmed 22q11.2DS.
- Anthropometric data compared to national surveillance databases.
- Risk factors analyzed using univariate and multivariate analyses.
Main Results:
- Overweight prevalence did not significantly differ from the general population.
- Obesity showed bimodal peaks at ages 11 and 17 years.
- Neuropsychiatric comorbidities and psychoactive medication use were associated with increased obesity risk; medication was an independent factor.
Conclusions:
- Obesity in 22q11.2DS appears influenced by pharmacological treatment, not intrinsic to the syndrome.
- Identifying vulnerable periods and modifiable risk factors is crucial.
- A multidisciplinary approach with metabolic screening and cautious psychotropic medication use is recommended.
Background:
22q11.2 deletion syndrome (22q11.2DS) is a complex and heterogeneous genetic disorder. While short stature is well-documented, data on weight excess in pediatric patients remain sparse and conflicting.
Objective:
To evaluate the prevalence of overweight and obesity in children and adolescents with 22q11.2DS when compared to the general Italian pediatric population and identify risk factors and periods of critical weight gain.
Methods:
In this single-center, retrospective study, 61 children with molecularly confirmed 22q11.2DS were followed up for 441 patient-years. Anthropometric data were evaluated and compared to national surveillance databases ("OKKio alla Salute" and "HBSC"). Risk factors for overweight and obesity were identified by univariate and multivariate analyses.
Results:
While overweight prevalence in 22q11.2DS patients did not differ significantly from that in the general population, obesity had a bimodal age distribution with peaks at 11 and 17 years. Both neuropsychiatric comorbidities and the use of psychoactive medication were significantly associated with an increased risk of overweight and obesity. In multivariate analysis, the use of psychoactive medication was the only independent risk factor.
Conclusions:
Obesity in 22q11.2DS may not be syndrome-intrinsic but is heavily influenced by pharmacological treatment. Identification of vulnerable periods and modifiable risk factors is crucial. A preventive, multidisciplinary approach with metabolic screening and cautious use of psychotropic medication is warranted to avoid obesity risk in this population.
Related Concept Videos
Obesity
Binge Eating Disorders
Inborn Errors of Metabolism
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Bulimia Nervosa

